Skip to main content
. 2017 May 1;17(6):1–75.
1 exp Prostatic Neoplasms/ (290920)
2 Prostate/ (74575)
3 exp Neoplasms/ (6500732)
4 2 and 3 (38049)
5 (prostat* adj3 (cancer* or carcinoma* or neoplas* or tumo?r* or adenoma* or adenocarcinoma* or malignan* or metasta*)).tw. (277087)
6 Prostatectomy/ (69779)
7 prostatectom*.tw. (63158)
8 or/1,4–7 (373736)
9 Genetic Testing/ (60447)
10 ((genetic* or gene or genes or genome or genomes or genomic* or 17-gene) adj2 (test or tests or testing or panel* or assess* or screen* or profil* or algorithm* or combinatorial or prognosis or prognostic*)).tw. (235791)
11 exp Gene Expression Profiling/ (171739)
12 ((gene expression adj (profiling* or monitoring* or analys?s or test or tests or testing)) or transcript expression analys?s or (transcriptome adj (analys?s or profiling*)) or (mrna adj differential display*)).tw. (69757)
13 ((cell cycle progression adj (score or scores or test or tests or testing or assay* or signature* or instrument*)) or (CCP adj (score or scores or test or tests or testing)) or cell cycle gene expression assay* or cell cycle proliferation gene* or RNA profiling test* or molecular assay* or prostate cancer assay* or genomic prostate score* or molecular diagnostic assay* or multigene expression assay*).tw. (5822)
14 or/9–13 (429710)
15 8 and 14 (6949)
16 prolaris*.tw. (31)
17 or/15–16 (6958)
18 economics/ (251267)
19 economics, medical/ or economics, pharmaceutical/ or exp economics, hospital/ or economics, nursing/ or economics, dental/ (735077)
20 economics.fs. (381957)
21 (econom* or price or prices or pricing or priced or discount* or expenditure* or budget* or pharmacoeconomic* or pharmaco-economic*).tw. (686871)
22 exp “costs and cost analysis”/ (510897)
23 cost*.ti. (234727)
24 cost effective*.tw. (250095)
25 (cost* adj2 (util* or efficacy* or benefit* or minimi* or analy* or saving* or estimate* or allocation or control or sharing or instrument* or technolog*)).ab. (156523)
26 models, economic/ (134522)
27 markov chains/ or monte carlo method/ (119887)
28 (decision adj1 (tree* or analy* or model*)).tw. (33792)
29 (markov or markow or monte carlo).tw. (99281)
30 quality-adjusted life years/ (26577)
31 (QOLY or QOLYs or HRQOL or HRQOLs or QALY or QALYs or QALE or QALEs).tw. (50975)
32 ((adjusted adj (quality or life)) or (willing* adj2 pay) or sensitivity analys*s).tw. (98325)
33 or/18–32 (2279891)
34 17 and 33 (242)
35 34 use pmoz,cctr,coch,dare,clhta (57)
36 17 use cleed (1)
37 or/35–36 (58)
38 limit 37 to english language [Limit not valid in CDSR,DARE; records were retained] (56)
39 limit 38 to yr=“2010 -Current” [Limit not valid in DARE; records were retained] (37)
40 exp prostate tumor/ (181348)
41 prostate/ (74575)
42 exp neoplasm/ (6495582)
43 and/41–42 (38033)
44 (prostat* adj3 (cancer* or carcinoma* or neoplas* or tumo?r* or adenoma* or adenocarcinoma* or malignan* or metasta*)).tw. (277087)
45 prostatectomy/ (69779)
46 prostatectom*.tw. (63158)
47 or/40,43–46 (359573)
48 genetic screening/ (88435)
49 ((genetic* or gene or genes or genome or genomes or genomic* or 17-gene) adj2 (test or tests or testing or panel* or assess* or screen* or profil* or algorithm* or combinatorial or prognosis or prognostic*)).tw. (235791)
50 gene expression profiling/ (171701)
51 ((gene expression adj (profiling* or monitoring* or analys?s or test or tests or testing)) or transcript expression analys?s or (transcriptome adj (analys?s or profiling*)) or (mrna adj differential display*)).tw. (69757)
52 ((cell cycle progression adj (score or scores or test or tests or testing or assay* or signature* or instrument*)) or (CCP adj (score or scores or test or tests or testing)) or cell cycle gene expression assay* or cell cycle proliferation gene* or RNA profiling test* or molecular assay* or prostate cancer assay* or genomic prostate score* or molecular diagnostic assay* or multigene expression assay*).tw. (5822)
53 or/48–52 (445179)
54 47 and 53 (6881)
55 prolaris*.tw. (31)
56 or/54–55 (6889)
57 Economics/ (251267)
58 Health Economics/ or exp Pharmacoeconomics/ (214674)
59 Economic Aspect/ or exp Economic Evaluation/ (394850)
60 (econom* or price or prices or pricing or priced or discount* or expenditure* or budget* or pharmacoeconomic* or pharmaco-economic*).tw. (686871)
61 exp “Cost”/ (510897)
62 cost*.ti. (234727)
63 cost effective*.tw. (250095)
64 (cost* adj2 (util* or efficacy* or benefit* or minimi* or analy* or saving* or estimate* or allocation or control or sharing or instrument* or technolog*)).ab. (156523)
65 Monte Carlo Method/ (50881)
66 (decision adj1 (tree* or analy* or model*)).tw. (33792)
67 (markov or markow or monte carlo).tw. (99281)
68 Quality-Adjusted Life Years/ (26577)
69 (QOLY or QOLYs or HRQOL or HRQOLs or QALY or QALYs or QALE or QALEs).tw. (50975)
70 ((adjusted adj (quality or life)) or (willing* adj2 pay) or sensitivity analys*s).tw. (98325)
71 or/57–70 (1871276)
72 56 and 71 (183)
73 limit 72 to english language [Limit not valid in CDSR,DARE; records were retained] (175)
74 limit 73 to yr=“2010 -Current” [Limit not valid in DARE; records were retained] (124)
75 74 use emez (89)
76 39 or 75 (126)
77 76 use pmoz (26)
78 76 use emez (89)
79 76 use coch (8)
80 76 use cctr (1)
81 76 use clhta (1)
82 76 use cleed (1)
83 76 use dare (0)
84 remove duplicates from 76 (104)